Q-Plex™ Pneumococcal Kit (9-Plex

Confirm delete?

Q-Plex^™ Pneumococcal Kit (9-Plex)

Zoom

Cat No: 34962

Assay Kits - More Assay Kits

The Q-Plex ™ Pneumococcal Kit (9-Plex) is a quantitative chemiluminescent assay (ELISA) allowing concurrent measurement in serum and plasma samples of human IgG antibodies reactive to Streptococcus pneumoniae serotypes 2, 10A, 11A, 15B, 17F, 19A, 2...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

QPlex Streptococcus Antipneumococcal

Product Overview:
The Q-Plex ™ Pneumococcal Kit (9-Plex) is a quantitative chemiluminescent assay (ELISA) allowing concurrent measurement in serum and plasma samples of human IgG antibodies reactive to Streptococcus pneumoniae serotypes 2, 10A, 11A, 15B, 17F, 19A, 20, 22F, and 33F polysaccharides. The Q-Plex™ Pneumococcal Kit (14-Plex) and Q-Plex™ Pneumococcal Kit (23-Plex) are also available for individual purchase. Q-Plex™ plates are built by absorbing multiple distinct capture antibodies in a defined array to the bottom of each well. Our high-quality reagents help ensure the accuracy of your results. See Item No. 28264 to view pricing and specifications for the Q-View™ Imager LS. Species: Human Sample Type: Serum Volume Required per Well: 0.25 µl, minimum Assay Length: 3 hours Intra-Assay Cross Reactivity: High levels of 19F may inhibit the detection of 12F. No cross-reactivity or interference detected between other analytes Assay Type: Indirect Detection Method: Q-View™ Chemiluminescent Imaging System Item No. 28264 Multiplex Format: 96-well solid plate [QuanSys Catalog No. 481649HU]

Size	1 ea
Shipping	wet ice
Custom Code	3822.19
UNSPSC code	41116104

Technical File

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Q-Plex™ Pneumococcal Kit (9-Plex)